康
00867
康哲藥業
12.310
-0.340-2.69%Closed16:08 05/08 HKT
OPEN/PREV CLOSE12.650/12.650
TODAY RANGE12.200-12.650
VOL5.67M
MARKET CAP30.03B
52 WEEK RANGE8.050-15.630
AVG VOL (3M)4.24M
% TURNOVER0.23%
TURNOVER69.96M
P/E (TTM)18.218
% RANGE3.56%
EPS(TTM)0.676
P/E(FORWARD)13.031
P/B1.559
BVPS7.895
DIVIDEND0.326
P/S3.303
BETA--
DIV YIELD2.65%
FREE FLOAT MKT CAP30.03B
SHARES OUTSTANDING2.44B
NEXT EARNINGS08/17-08/21
FREE FLOAT2.44B
LOT SIZE1000
EX-DATE04/27/2026
News
Press Releases
Financial Reports
Profile
Reuters·04/01 11:11
China Medical System Holdings announces annual general meeting notice
Reuters·04/01 11:06
China Medical System releases 2025 ESG report
Reuters·04/01 10:57
China Medical System publishes 2025 annual report
Simply Wall St·03/25 17:13
China Medical System Holdings (SEHK:867) Valuation After Desidustat Approval And Recent Share Price Pullback
Simply Wall St·03/20 15:10
China Medical System Wins Desidustat Approval Raising Nephrology Growth Questions
Simply Wall St·03/18 10:05
China Medical System Holdings SEHK 867 Margin Decline Tests Bullish Growth Narrative
Reuters·03/16 23:04
China Medical System Holdings files list of directors with HKEX
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.